postmenopausal women may be able to reduce the risk of breast cancer with the osteoporosis drug Evista that was approved today by FDA.
Ads by Google
Myriad Genetic Laboratories on Monday began a direct-to-consumer advertising campaign in Boston; Hartford, Conn.; New York City; and Providence, R.I., of its genetic test, BRCAnalysis, which identifies the BRCA1 and BRCA2 genetic mutations, the Wall Street Journal reports.
Black women in the United States are more likely than white women to have breast tumors that are ER-negative.
More than 10 percent of women with breast cancer stopped taking a commonly prescribed drug because of joint and muscle pain.
Three clinical data abstracts about Roche's oral chemotherapy treatment Xeloda have been accepted for presentation at the 2007 Breast Cancer Symposium in San Francisco.
Black women are more likely than other women to develop breast tumors that do not respond to common hormone-based treatments.
Imaging Diagnostic Systems has shipped a CT Laser Mammography (CTLM) system to the Universiti Putra Malaysia (UPM) in Kuala Lumpur, Malaysia, the first such scanner in the country.
Two Leeds scientists have received research grants from Breast Cancer Campaign, the only charity that specialises in funding independent breast cancer research throughout the UK. The project grants, worth over
The use of hypnosis prior to breast cancer surgery reduced the amount of anesthesia administered during the operation, the level of pain reported afterwards, and the time and cost of the procedure
Foods that contain acrylamide are unlikely to cause breast cancer in women.
Cardiff University is at the forefront in the fight against breast cancer with cutting-edge research which could lead to better treatments for the disease.
Dendreon Corporation published results from a Phase 1 study f NEUVENGE, an investigational active cellular immunotherapy for breast cancer patients.
Risk factors of breast cancer are not linked as previously assumed.
Researchers may have unlocked the mechanisms that silence the estrogen receptor gene alpha during breast cancer.
According to a new study natural compounds in Concord grape juice protected healthy human breast cells from DNA damage.
The majority of breast cancer survivors consider themselves stronger after having the disease.
International guidelines for the detection, care and management of breast cancer are now available in Spanish.
Women with early stage breast cancer now have a new treatment option available to help reduce recurrence of the disease using a miniaturized X-ray source.
Women with early stage breast cancer who receive a newer type of radiation called intensity modulated radiation therapy develop significantly fewer side effects.
Rena Rowan Breast Center was one of the beneficiaries of the televised fundraiser that supports breast cancer research and patient education.
Researchers have identified a gene linked to the development of an aggressive form of breast cancer.
Treating a breast cancer patient with chemotherapy before breast cancer surgery does not harm the woman's health.
FDA recommending that Eli Lilly's bone-strengthening drug raloxifene, sold under the brand-name Evista, be approved to reduce the risk of breast cancer.
FDA voted to recommend approval of Eli Lilly and Company's osteoporosis drug EVISTA for a new use to reduce invasive breast cancer risk.
FDA will consider whether Eli Lilly's bone-strengthening drug raloxifene should be approved to reduce the risk of breast cancer in some women.
Breast cancer survivors whose disease has returned can maintain loving relationships and fulfilling sexual lives.
A diet that surpasses government recommendations for daily servings of fruits and vegetables does not boost breast cancer survival rates in women.
FDA approved the first molecular-based laboratory test for detecting whether breast cancer has spread (metastasized) to nearby lymph nodes.